A curated listing of global health funding opportunities.
Apply for funding for internationally collaborative projects to understand the ecological, evolutionary and social drivers of infectious disease transmission in animals, humans and plants, using a quantitative or mathematical approach combined with qualitative principles.
You must be based at a UK research organisation eligible for funding from UKRI or Defra and collaborate with a partner from the US. You can also have partners from China and Israel to form tri or quadrilateral collaborations.
The full economic cost of your project can be up to £1 million, funding available for up to four years.
The Medical Research Council invites outline applications for its research grants under the applied global health research programme. They are looking to develop a portfolio of high-quality global research which will be diverse, promote multidisciplinarity and strengthen global health research capacity. They encourage applications from project leads based in low and middle-income countries (LMICs) and UK, working in equitable partnership with LMIC researchers. This call is repeated once a year. Stage one application opening date: 20 August 2024 9:00am.
The GHIT Fund announces the Request for Proposals (RFP) for the development of new medicines, vaccines, diagnostics for infectious diseases that are prevalent in the developing world. Proposed projects should address health needs in the developing world or fill a gap in global health technologies for infectious diseases. The proposed collaboration projects should be no more than two years in duration and may focus on a broad array of R&D activities, including:
- Lead optimization
- Preclinical Development (in-vivo studies, formulation development, chemistry and process validation)
- Clinical Development (Phase 1, 2, or 3 studies, manufacturing scale-up)
- Parallel or concurrent development of multiple interventions (e.g., development of new drugs alongside improved diagnostic tools for disease control, advancing multiple promising drug candidates concurrently)
- Activities to support licensure and WHO prequalification
Interested applicants can find detailed information on the RFP and the Intent to Apply form on their website. Please note interested applicants must complete the Intent to Apply (ITA) form and submit this to the GHIT Fund by 28 November 2024. Full applications are then due 16 January 2025.
The GHIT Fund announces the Request for Proposals (RFP) for the Target Research Platform (TRP). The TRP is currently focused on technologies and approaches that address unmet or priority needs within malaria, tuberculosis, Neglected Tropical Diseases and disease with pandemic potential listed in the GHIT Intent to Apply form.
Proposed projects should primarily originate from or materially involve Japanese science and technology and partnerships will need to be between eligible Japanese and non-Japanese organizations.
Interested applicants can find detailed information on the RFP and the Intent to Apply form. Please note interested applicants must complete the Intent to Apply (ITA) form and submit this to the GHIT Fund by 28 November 2024. Full applications are then due 16 January 2025.
ABOUT
Action for Women’s Health is a $250 million global open call launched by Pivotal that will fund organizations around the world that are improving women’s mental and physical health. Eligible organizations serve women and have a record of improving women’s mental or physical health. They should center equity in their approach and be poised to scale their work to strengthen the health of more women. Organizations from around the world are invited to apply.
Amount: Maximum award is USD 5,000,000.
Deadline: Applicants must register to apply before 4 p.m. U.S. Central Time on Tuesday, December 3, 2024. Once registered, applicants must submit an online application before 4 p.m. U.S. Central Time on Friday, January 10, 2025.
Learn more about the Lever for Change: Action for Women’s Health
This call will fund research to evaluate and further develop scalable digital interventions to advance early intervention in depression, anxiety and psychosis. Teams must have the research expertise required to drive the proposed research, an organisation which can take the intervention to scale (whether a company or not-for-profit) and lived experience experts. This call is open to interventions designed to lead to reductions in symptom(s) and/or functional impairments related to anxiety, depression or psychosis. We expect teams to already have a minimum viable product and feasibility data for their intervention.
The Global Health Research Professorship award is NIHR’s flagship career development award. It aims to fund research leaders to promote effective translation of research and to strengthen research leadership at the highest academic levels.
The Global Health Research Professorship programme supports outstanding academics to work at professorial level. The programme funds researchers undertaking research that aims to specifically and primarily benefit people in LMICs eligible for Official Development Assistance (ODA).
The award provides an extensive support package alongside the professorship, to include support posts, research costs and a leadership and development programme.
The scheme is open to all health, public health and social care research and methodology professions. Applicants must be nominated by their host institution, so see details of obligatory internal coordinated bid.
This award will fund projects to advance understanding of how heat impacts anxiety, depression, and psychosis in the most impacted groups globally through biological, psychological, and/or social mechanisms. Teams must bring together mental health and climate expertise as well as additional expertise as relevant. Consistent with the Wellcome approach to mental health research, it is expected that research teams to include relevant lived experience of mental health problems, unless there is a strong justification for not doing so. Researchers can be based in institutions anywhere in the world (apart from mainland China and countries that are the target of international sanctions). Scope check deadline 18 December 2024.
ABOUT
This award will support studies that explore the mechanisms and triggers for fungal adaptation, particularly in environments that are associated with disease and/or impacted by climate change. Awardees will generate important breakthroughs in the field, strengthen research networks and empower future leaders in this field.
Amount: Up to £3 million for up to 5 years.
ELIGIBILITY
Established and mid-career researchers
Learn more about the Wellcome - Biology of Fungal Adaptation Scheme
ABOUT
This funding call will generate a body of evidence on the health effects of climate change mitigation interventions in low- and middle-income countries (LMICs). This award will fund transdisciplinary research teams, led by an applicant at an LMIC-based institution. Research funded will investigate health effects alongside the social and economic impacts of planned or implemented greenhouse gas mitigation strategies. Research will reflect local priorities and produce evidence to drive positive climate and health outcomes. Preliminary application deadline: 18 February 2025.
AMOUNT
£500,000-£2 million per project for 2 - 4 years
Frequency: One-off
ELIGIBILITY
Lead applicant career stage: Established researcher
Co-applicants: Accepted
Administering organisation location: Low- or middle-income countries (apart from mainland China)
ABOUT
The Medical Research Future Fund (MRFF) Australia, the National Health and Medical Research Council (NHMRC) Australia and National Institute for Health and Care Research (NIHR) UK are inviting applications for ambitious platform studies in areas of unmet medical need. The platform must be internationally collaborative, with joint leads based in Australia and the United Kingdom.
Applications to this funding opportunity must describe a platform trial seeking to evaluate a number of specified technologies. Each technology must have sufficient clinical, human proof of concept to justify a definitive efficacy study. This call is for either Phase 2 or Phase 3 focused platforms, where there is a pipeline of technologies which justifies a platform approach. This call will not support funding for studies aiming to run platforms seamlessly from phase 2 into phase 3. See call specifications for more details.
The funder is holding a webinar (1.5hrs) to support applicants to this funding opportunity on 19 November 2024, 08:00 UK (UTC+0)/19:00 AEDT (UTC+11). To register for the webinar, please sign up via their online form.
Amount: Aiming to fund 1 to 3 platforms for up to 7 Years. NHMRC and MRFF will fund the Australian research component and the NIHR will fund the UK research component of successful applications.
Learn more about the NIHR: Australia-UK platform studies in areas of unmet clinical need